Bank of America Issues Pessimistic Forecast for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its price target decreased by analysts at Bank of America from $50.00 to $44.50 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price target points to a potential upside of 48.43% from the company’s previous close.

A number of other research firms have also issued reports on ACHC. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Barclays lowered Acadia Healthcare from an “overweight” rating to an “equal weight” rating and dropped their target price for the company from $43.00 to $35.00 in a report on Friday. KeyCorp raised Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a report on Tuesday, January 7th. Finally, TD Cowen dropped their price objective on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company. According to MarketBeat, Acadia Healthcare has a consensus rating of “Hold” and a consensus price target of $59.56.

Acadia Healthcare Trading Down 25.5 %

ACHC opened at $29.98 on Friday. The firm has a market cap of $2.78 billion, a price-to-earnings ratio of 9.83, a price-to-earnings-growth ratio of 1.46 and a beta of 1.30. Acadia Healthcare has a 52 week low of $29.79 and a 52 week high of $86.56. The business’s 50 day moving average is $42.10 and its two-hundred day moving average is $51.78. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ACHC. Public Employees Retirement System of Ohio purchased a new stake in Acadia Healthcare during the fourth quarter worth $1,293,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Acadia Healthcare by 22.0% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 313,709 shares of the company’s stock worth $12,439,000 after purchasing an additional 56,647 shares in the last quarter. Voloridge Investment Management LLC purchased a new stake in Acadia Healthcare during the fourth quarter worth $15,770,000. Squarepoint Ops LLC purchased a new stake in Acadia Healthcare during the fourth quarter worth $1,087,000. Finally, Two Sigma Investments LP purchased a new stake in Acadia Healthcare during the fourth quarter worth $7,648,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.